$CYCA
CYTTA CORP. Stock $cyca

$cyca Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000147793224000156 Filed on January 12, 2024

Income Statement

Concept	2024 Q1	2023 Q3	2023
Revenue	$0.00	$8.120K	$30.06K
YoY Change	-100.0%	147.56%	393.66%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$895.2K	$1.597M	$4.606M
YoY Change	38.07%	30.13%	-8.07%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$10.51K	$10.88K	$45.43K
YoY Change	-10.48%	-8.65%	-4.58%
% of Gross Profit
Operating Expenses	$905.7K	$1.608M	$4.651M
YoY Change	37.2%	29.76%	-8.04%
Operating Profit	-$905.7K		-$4.621M
YoY Change	38.91%		-381.99%
Interest Expense	-$82.83K	-$61.72K	$107.2K
YoY Change	632.36%	-28154.55%	119.52%
% of Operating Profit
Other Income/Expense, Net	$82.83K		$107.0K
YoY Change	632.5%		123.3%
Pretax Income	-$988.5K	-$1.661M	-$4.728M
YoY Change	49.03%	34.47%	-7.29%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$988.5K	-$1.661M	-$4.728M
YoY Change	49.03%	34.47%	-7.29%
Net Earnings / Revenue		-20461.08%	-15730.64%
Basic Earnings Per Share
Diluted Earnings Per Share	$0.00	$0.00	-$0.01
COMMON SHARES
Basic Shares Outstanding	434.7M shares	418.4M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q1	2023 Q3	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$441.7K	$674.8K	$674.8K
YoY Change	106.21%	-10.63%	-10.63%
Cash & Equivalents	$441.7K	$674.8K
Short-Term Investments
Other Short-Term Assets	$521.2K	$987.0K	$987.0K
YoY Change	339.39%	2899.94%	2899.94%
Inventory
Prepaid Expenses	$521.2K	$987.0K
Receivables
Other Receivables
Total Short-Term Assets	$962.9K	$1.662M	$1.662M
YoY Change	189.32%	110.88%	110.88%
LONG-TERM ASSETS
Property, Plant & Equipment	$56.47K	$77.56K	$77.56K
YoY Change	-43.16%	-36.94%	-36.94%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$351.1K	$561.8K	$561.8K
YoY Change
Total Long-Term Assets	$407.6K	$639.3K	$639.3K
YoY Change	310.26%	419.83%	419.82%
TOTAL ASSETS
Total Short-Term Assets	$962.9K	$1.662M	$1.662M
Total Long-Term Assets	$407.6K	$639.3K	$639.3K
Total Assets	$1.370M	$2.301M	$2.301M
YoY Change	217.12%	152.59%	152.59%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.204M	$1.319M	$1.319M
YoY Change	121.57%	631.04%	631.04%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$43.20K	$40.00K	$40.00K
YoY Change	8.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$3.036M	$2.561M	$1.395M
YoY Change	336.45%	470.21%	210.47%
LONG-TERM LIABILITIES
Long-Term Debt	$1.755M	$1.167M	$1.167M
YoY Change	8804.11%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$1.755M	$1.167M	$1.167M
YoY Change	8804.11%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.036M	$2.561M	$1.395M
Total Long-Term Liabilities	$1.755M	$1.167M	$1.167M
Total Liabilities	$3.036M	$2.561M	$2.561M
YoY Change	324.43%	470.21%	470.21%
SHAREHOLDERS EQUITY
Retained Earnings	-$34.65M	-$32.60M
YoY Change	16.91%	16.96%
Common Stock	$441.9K	$426.8K
YoY Change	12.51%	12.39%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$1.665M	-$260.4K	-$260.4K
YoY Change
Total Liabilities & Shareholders Equity	$1.370M	$2.301M	$2.301M
YoY Change	217.12%	152.59%	152.59%

Cashflow Statement

Concept	2024 Q1	2023 Q3	2023
OPERATING ACTIVITIES
Net Income	-$988.5K	-$1.661M	-$4.728M
YoY Change	49.03%	34.47%	-7.29%
Depreciation, Depletion And Amortization	$10.51K	$10.88K	$45.43K
YoY Change	-10.48%	-8.65%	-4.58%
Cash From Operating Activities	-$466.1K	-$317.2K	-$1.435M
YoY Change	103.4%	-61.04%	-39.73%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	517.5K	505.0K	$1.355M
YoY Change	72.5%		-54.28%
NET CHANGE
Cash From Operating Activities	-466.1K	-317.2K	-$1.435M
Cash From Investing Activities
Cash From Financing Activities	517.5K	505.0K	$1.355M
Net Change In Cash	51.40K	187.8K	-$80.30K
YoY Change	-27.44%	-123.06%	-113.8%
FREE CASH FLOW
Cash From Operating Activities	-$466.1K	-$317.2K	-$1.435M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001383088
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-30
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	379760670	shares
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	333-257458
CY2023	dei	Entity Registrant Name EntityRegistrantName	CYTTA CORP.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-0505761
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	5450 W Sahara Ave Suite 300A
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Las Vegas
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	NV
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	89146
CY2023	dei	City Area Code CityAreaCode	702
CY2023	dei	Local Phone Number LocalPhoneNumber	900-7022
CY2023	dei	Security12g Title Security12gTitle	Common Stock, $0.001 par value
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q1	dei	Entity Public Float EntityPublicFloat	16191132	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	434718920	shares
CY2023	dei	Auditor Firm AuditorFirmId	273
CY2023	dei	Auditor Name AuditorName	Prager Metis CPAs, LLC
CY2023	dei	Auditor Location AuditorLocation	Hackensack, New Jersey
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	674824	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	755122	usd
CY2023Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	986976	usd
CY2022Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	32897	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	1661800	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	788019	usd
CY2023Q3	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	561776	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	77558	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	122990	usd
CY2023Q3	us-gaap	Assets Assets	2301134	usd
CY2022Q3	us-gaap	Assets Assets	911009	usd
CY2023Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	546335	usd
CY2022Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	180633	usd
CY2023Q3	us-gaap	Related Party Deposit Liabilities RelatedPartyDepositLiabilities	772532	usd
CY2022Q3	us-gaap	Related Party Deposit Liabilities RelatedPartyDepositLiabilities	180407	usd
CY2023Q3	us-gaap	Dividends Payable Current DividendsPayableCurrent	33427	usd
CY2022Q3	us-gaap	Dividends Payable Current DividendsPayableCurrent	33427	usd
CY2023Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	2411	usd
CY2022Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	0	usd
CY2023Q3	us-gaap	Notes Payable Current NotesPayableCurrent	40000	usd
CY2022Q3	us-gaap	Notes Payable Current NotesPayableCurrent	0	usd
CY2023Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1166788	usd
CY2022Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	0	usd
CY2023Q3	cyca	Stock To Be Issued StockToBeIssued	0	usd
CY2022Q3	cyca	Stock To Be Issued StockToBeIssued	54750	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	2561493	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	449217	usd
CY2023Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	usd
CY2022Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	usd
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	426831170	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	379760670	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	426832	usd
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	379761	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	31915639	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	27956388	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-32603480	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-27875007	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-260359	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	461792	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2301134	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	911009	usd
CY2023	us-gaap	Revenues Revenues	30059	usd
CY2022	us-gaap	Revenues Revenues	6089	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1843501	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1142477	usd
CY2023	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	2807989	usd
CY2022	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	3915778	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	4651490	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	5058255	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-4621431	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-5052166	usd
CY2023	us-gaap	Interest Expense InterestExpense	107192	usd
CY2022	us-gaap	Interest Expense InterestExpense	48831	usd
CY2023	us-gaap	Interest Income Other InterestIncomeOther	150	usd
CY2022	us-gaap	Interest Income Other InterestIncomeOther	895	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	107042	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	47936	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4728473	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5100102	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-4728473	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-5100102	usd
CY2023	cyca	Basic And Diluted Earnings Per Share Basic And Diluted BasicAndDilutedEarningsPerShareBasicAndDiluted	-0.01
CY2022	cyca	Basic And Diluted Earnings Per Share Basic And Diluted BasicAndDilutedEarningsPerShareBasicAndDiluted	-0.01
CY2023	cyca	Weighted Average Shares Outstanding Basic And Diluted WeightedAverageSharesOutstandingBasicAndDiluted	396241022	shares
CY2022	cyca	Weighted Average Shares Outstanding Basic And Diluted WeightedAverageSharesOutstandingBasicAndDiluted	358355926	shares
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	461792	usd
CY2023	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	2175819	usd
CY2023	cyca	Common Stock Issued For Accounts Payable And Accrued Liabilities Amount CommonStockIssuedForAccountsPayableAndAccruedLiabilitiesAmount	67440	usd
CY2023	cyca	Common Stock Issued For Stock Payable Amount CommonStockIssuedForStockPayableAmount	54750	usd
CY2023	cyca	Stock Options And Warrants Vested To Purchase Common Stock StockOptionsAndWarrantsVestedToPurchaseCommonStock	1521312	usd
CY2023	cyca	Common Stock And Warrants Issued For Cash Amount CommonStockAndWarrantsIssuedForCashAmount	100000	usd
CY2023	cyca	Warrants Issued In Conjunction With Notes Payable WarrantsIssuedInConjunctionWithNotesPayable	87001	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-4728473	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-260359	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	866244	usd
CY2022	cyca	Series F Preferred Stock Issued For Cash Amount SeriesFPreferredStockIssuedForCashAmount	2963500	usd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	1407150	usd
CY2022	cyca	Common Stock Issued For Accounts Payable Amount CommonStockIssuedForAccountsPayableAmount	325000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-5100102	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	461792	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-4728473	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-5100102	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	3136341	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	2178973	usd
CY2023	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	38790	usd
CY2022	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	0	usd
CY2023	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt	20171	usd
CY2022	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt	0	usd
CY2023	us-gaap	Depreciation Depreciation	45432	usd
CY2022	us-gaap	Depreciation Depreciation	47615	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	0	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	78765	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	0	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	27694	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-49282	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-1159	usd
CY2023Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	0.025
CY2023	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	100000	usd
CY2023	cyca	Increase Decrease In Vendor Deposits IncreaseDecreaseInVendorDeposits	0	usd
CY2022	cyca	Increase Decrease In Vendor Deposits IncreaseDecreaseInVendorDeposits	50400	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	69718	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	159578	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	29594	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	167856	usd
CY2023	cyca	Increase Decrease In Dividend Payable IncreaseDecreaseInDividendPayable	0	usd
CY2022	cyca	Increase Decrease In Dividend Payable IncreaseDecreaseInDividendPayable	12394	usd
CY2023	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	2411	usd
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-3588	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1435298	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2381574	usd
CY2023	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	100000	usd
CY2022	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	2963500	usd
CY2023	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	40000	usd
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	usd
CY2023	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	1215000	usd
CY2022	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	0	usd
CY2023	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	usd
CY2022	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1355000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2963500	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-80298	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	581926	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	755122	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	173196	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	674824	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	755122	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2023	cyca	Issuance Of Common Stock For Accounts Payable And Accrued Liabilities IssuanceOfCommonStockForAccountsPayableAndAccruedLiabilities	118218	usd
CY2022	cyca	Issuance Of Common Stock For Accounts Payable And Accrued Liabilities IssuanceOfCommonStockForAccountsPayableAndAccruedLiabilities	300000	usd
CY2023	cyca	Issuance Of Common Stock For Accrued Expenses Related Party IssuanceOfCommonStockForAccruedExpensesRelatedParty	55393	usd
CY2022	cyca	Issuance Of Common Stock For Accrued Expenses Related Party IssuanceOfCommonStockForAccruedExpensesRelatedParty	0	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-32603480	usd
CY2023	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	4000000	shares
CY2022Q3	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	122990	usd
CY2023	us-gaap	Depreciation Depreciation	45432	usd
CY2022	us-gaap	Depreciation Depreciation	47615	usd
CY2023	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	1215000	usd
CY2023	cyca	Promissory Notes Issued Amount PromissoryNotesIssuedAmount	40000	usd
CY2023	cyca	Exchange For Note Issuances Received ExchangeForNoteIssuancesReceived	1255000	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reported period. Actual results could differ from those estimates.</p>
CY2023Q3	cyca	Prepaid Expenses Beginning Balance PrepaidExpensesBeginningBalance	32897	usd
CY2022Q3	cyca	Prepaid Expenses Beginning Balance PrepaidExpensesBeginningBalance	772394	usd
CY2023Q3	cyca	Value Of Common Stock Issued ValueOfCommonStockIssued	2399708	usd
CY2022Q3	cyca	Value Of Common Stock Issued ValueOfCommonStockIssued	894841	usd
CY2023Q3	cyca	Amortization Of Stock Based Compensation AmortizationOfStockBasedCompensation	-933135	usd
CY2022Q3	cyca	Amortization Of Stock Based Compensation AmortizationOfStockBasedCompensation	-1635492	usd
CY2023Q3	cyca	Prepaid Expense From Other Activity PrepaidExpenseFromOtherActivity	49282	usd
CY2022Q3	cyca	Prepaid Expense From Other Activity PrepaidExpenseFromOtherActivity	1154	usd
CY2023Q3	cyca	Prepaid Expenses Ending Balance PrepaidExpensesEndingBalance	1548752	usd
CY2022Q3	cyca	Prepaid Expenses Ending Balance PrepaidExpensesEndingBalance	32897	usd
CY2023Q3	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	561776	usd
CY2022Q3	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	0	usd
CY2023Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	986976	usd
CY2022Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	32897	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	78765	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company’s financial instruments that are exposed to concentrations of credit risk primarily consist of its cash and cash equivalents and related party payables it will likely incur in the near future. The Company places its cash and cash equivalents with financial institutions of high credit worthiness. At times, its cash and cash equivalents with a particular financial institution may exceed any applicable government insurance limits. The Company’s management plans to assess the financial strength and credit worthiness of any parties to which it extends funds, and as such, it believes that any associated credit risk exposures are limited.</p>
CY2023Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	230900	usd
CY2022Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	230900	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	153342	usd
CY2022Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	107910	usd
CY2023Q3	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	77558	usd
CY2020Q4	cyca	Annual Lease Payment Related Party AnnualLeasePaymentRelatedParty	50000	usd
CY2023Q3	cyca	Accounts Payables Related Parties Current AccountsPayablesRelatedPartiesCurrent	772532	usd
CY2022Q3	cyca	Accounts Payables Related Parties Current AccountsPayablesRelatedPartiesCurrent	180407	usd
CY2023Q3	cyca	Accounts Payables Related Parties Current AccountsPayablesRelatedPartiesCurrent	772532	usd
CY2022Q3	cyca	Accounts Payables Related Parties Current AccountsPayablesRelatedPartiesCurrent	180407	usd
CY2023Q1	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.08	pure
CY2023Q1	cyca	Promissory Note Face Value PromissoryNoteFaceValue	40000	usd
CY2023Q1	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2024-01-10
CY2023Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.025
CY2023Q1	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	1
CY2023Q1	us-gaap	Class Of Warrant Or Right Unissued ClassOfWarrantOrRightUnissued	2000000	shares
CY2023Q1	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	1
CY2023Q3	us-gaap	Class Of Warrant Or Right Unissued ClassOfWarrantOrRightUnissued	2000000	shares
CY2023Q1	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	1
CY2023Q3	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	1166788	usd
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q3	us-gaap	Common Stock No Par Value CommonStockNoParValue	0.001
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	426831170	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	379760670	shares
CY2023	cyca	Common Stock Issued For Services Shares CommonStockIssuedForServicesShares	41575000	shares
CY2023	cyca	Common Stock Issued For Services Amount CommonStockIssuedForServicesAmount	2175819	usd
CY2023	cyca	Common Stock Issued For Payment Of Account Payable Share CommonStockIssuedForPaymentOfAccountPayableShare	1440750	shares
CY2023	cyca	Common Stock Issued For Payment Of Account Payable CommonStockIssuedForPaymentOfAccountPayable	47269	usd
CY2023	cyca	Commonstock Issued Settlement Of Stock Payable CommonstockIssuedSettlementOfStockPayable	67440	usd
CY2023	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt	20171	usd
CY2023	cyca	Common Stock Issued CommonStockIssued	54750	shares
CY2022	cyca	Common Stock Issued For Services Shares CommonStockIssuedForServicesShares	9539286	shares
CY2022	cyca	Common Stock Issued For Services Amount CommonStockIssuedForServicesAmount	1407150	usd
CY2022	cyca	Common Stock Issued For Payment Of Account Payable Share CommonStockIssuedForPaymentOfAccountPayableShare	1064757	shares
CY2022	cyca	Common Stock Issued For Payment Of Account Payable CommonStockIssuedForPaymentOfAccountPayable	325000	usd
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q3	cyca	Common Stock Shares To Be Issued CommonStockSharesToBeIssued	323583	usd
CY2022	cyca	Common Stock Issued CommonStockIssued	4000000	shares
CY2022	cyca	Reduction In Capital Stcok To Be Issued ReductionInCapitalStcokToBeIssued	268833	usd
CY2023	cyca	Reduction In Capital Stcok To Be Issued ReductionInCapitalStcokToBeIssued	54750	usd
CY2023Q3	cyca	Capital Stock To Be Issued CapitalStockToBeIssued	0	usd
CY2022Q3	cyca	Capital Stock To Be Issued CapitalStockToBeIssued	54750	usd
CY2023Q1	cyca	Issuance Of Restricted Common Stock Shares IssuanceOfRestrictedCommonStockShares	10000000	shares
CY2023Q1	cyca	Purchase Of Warrant Common Stock Value PurchaseOfWarrantCommonStockValue	449651	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	364324	usd
CY2023Q3	us-gaap	Share Price SharePrice	0.04
CY2022	cyca	Operating Income Losses OperatingIncomeLosses	1638878	usd
CY2022	cyca	Less Valuation Allowance LessValuationAllowance	-1638878	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2023Q3	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	9396000	usd
CY2023	cyca	Software Products SoftwareProducts	32470	usd
CY2023	us-gaap	Recognition Of Deferred Revenue RecognitionOfDeferredRevenue	30059	usd
CY2022	us-gaap	Recognition Of Deferred Revenue RecognitionOfDeferredRevenue	6089	usd
CY2023	us-gaap	Deferred Revenue Additions DeferredRevenueAdditions	2411	usd

Files In Submission

Name	View Source	Status
cyca-20230930_def.xml	Edgar Link	unprocessable
0001477932-24-000156-index-headers.html	Edgar Link	pending
0001477932-24-000156-index.html	Edgar Link	pending
0001477932-24-000156.txt	Edgar Link	pending
0001477932-24-000156-xbrl.zip	Edgar Link	pending
cyca-20230930.xsd	Edgar Link	pending
cyca_10k.htm	Edgar Link	pending
cyca_ex311.htm	Edgar Link	pending
cyca_ex312.htm	Edgar Link	pending
cyca_ex321.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
cyca-20230930_cal.xml	Edgar Link	unprocessable
cyca-20230930_pre.xml	Edgar Link	unprocessable
cyca-20230930_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
cyca_10k_htm.xml	Edgar Link	completed
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CYCA
CYTTA CORP. Stock $cyca

2024 Q1 Form 10-K Financial Statement

#000147793224000156 Filed on January 12, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CYCA CYTTA CORP. Stock $cyca

2024 Q1 Form 10-K Financial Statement

#000147793224000156 Filed on January 12, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CYCA
CYTTA CORP. Stock $cyca